NXGN.TA Gross Margin

The Gross Margin of Nextgen Biomed Ltd (NXGN.TA) is 36.77%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

NXGN.TA Gross Margin - Historical Value

Date	Value
2024-12-31	36.77%

NXGN.TA Gross Margin - Peers Comparison

Ticker	Name	Value
DP3.VN	Central Pharmaceutical JSC No3	66.12%
KREBSBIO.NS	Krebs Biochemicals and Industries Ltd	43.28%
LGP.AX	Little Green Pharma Ltd	53.18%
858.HK	Extrawell Pharmaceutical Holdings Ltd	48.70%
SEMG.TA	Seach Medical Group Ltd	30.96%
CSURE.TA	Cannassure Therapeutics Ltd	972.00%
TEVA.TA	Teva Pharmaceutical Industries Ltd	50.12%
TKUN.TA	Tikun Olam Cannbit Pharmaceuticals Ltd	-3.48%
540737.BO	Shree Ganesh Remedies Ltd	48.48%
PAA.AX	Neurizon Therapeutics Ltd	79.81%
AC8.AX	Auscann Group Holdings Ltd	100.00%
ACR.AX	Acrux Ltd	51.14%
BAFNAPH.NS	Bafna Pharmaceuticals Ltd	32.60%
CGB.AX	Cann Global Ltd	-13.90%
42C.SI	IX Biopharma Ltd	17.59%
4596.T	Kubota Pharmaceutical Holdings Co Ltd	81.03%
ZOTA.NS	Zota Health Care Ltd	44.51%
532384.BO	Tyche Industries Ltd	52.91%
LIFE.ME	Farmsintez PAO	22.24%
NYR.AX	Nyrada Inc	-348.25%
PNAX.TA	Panaxia Labs Israel Ltd	-52.86%
RNO.AX	Rhinomed Ltd	74.82%
506879.BO	Gujarat Themis Biosyn Ltd	59.88%
AGH.AX	Althea Group Holdings Ltd	60.70%
AVE.AX	Avecho Biotechnology Ltd	59.32%
BLT.NZ	BLIS Technologies Ltd	83.48%
ECS.AX	ECS Botanics Holdings Ltd	36.32%